异动解读｜康方生物盘中下跌3.35%，ASCO利好兑现后延续回调跌至52周低位附近

行情直击06-10

6月10日，康方生物盘中下跌3.35%，报85.85港元，成交额3.65亿港元，股价已逼近52周低点82.15港元，较6月1日ASCO数据公布后高点累计跌幅逾25%。

消息面上，该股延续ASCO利好兑现后的持续回调走势。此前公司核心产品依沃西联合化疗HARMONi-6研究在ASCO全体会议公布OS阳性结果，事件驱动型资金在利好落地后持续获利了结。同时，外媒关于美方可能限制对中国生物技术领域投资的传闻持续扰动市场情绪，生物科技板块整体承压，信达生物跌2.26%、百济神州跌0.31%、荣昌生物跌1.37%。尽管近期多家机构维持买入评级并给出远高于当前股价的目标价，但短线抛压与板块资金外流仍主导股价走势。

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1125573325?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-10 10:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125573325","market":"us","top_or_hot":-1,"title":"异动解读｜康方生物盘中下跌3.35%，ASCO利好兑现后延续回调跌至52周低位附近","media":"行情直击","content":"<p><p>6月10日，康方生物盘中下跌3.35%，报85.85港元，成交额3.65亿港元，股价已逼近52周低点82.15港元，较6月1日ASCO数据公布后高点累计跌幅逾25%。</p><p>消息面上，该股延续ASCO利好兑现后的持续回调走势。此前公司核心产品依沃西联合化疗HARMONi-6研究在ASCO全体会议公布OS阳性结果，事件驱动型资金在利好落地后持续获利了结。同时，外媒关于美方可能限制对中国生物技术领域投资的传闻持续扰动市场情绪，生物科技板块整体承压，信达生物跌2.26%、百济神州跌0.31%、荣昌生物跌1.37%。尽管近期多家机构维持买入评级并给出远高于当前股价的目标价，但短线抛压与板块资金外流仍主导股价走势。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜康方生物盘中下跌3.35%，ASCO利好兑现后延续回调跌至52周低位附近</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜康方生物盘中下跌3.35%，ASCO利好兑现后延续回调跌至52周低位附近\n</h2>\n\n<h4 class=\"meta\">\n\n2026-06-10 10:04 北京时间&nbsp;&nbsp;&nbsp;<strong>行情直击</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月10日，康方生物盘中下跌3.35%，报85.85港元，成交额3.65亿港元，股价已逼近52周低点82.15港元，较6月1日ASCO数据公布后高点累计跌幅逾25%。消息面上，该股延续ASCO利好兑现后的持续回调走势。此前公司核心产品依沃西联合化疗HARMONi-6研究在ASCO全体会议公布OS阳性结果，事件驱动型资金在利好落地后持续获利了结。同时，外媒关于美方可能限制对中国生物技术领域投资的传闻...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09926","symbol_name":"康方生物","start_time":0,"source_url":"","article_id":"1125573325","we_media_id":"1059448697","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125573325","pubTimestamp":1781057085,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"行情直击","introduction":"个股异动一手消息解读","home_visible":1,"id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"6月10日，康方生物盘中下跌3.35%，报85.85港元，成交额3.65亿港元，股价已逼近52周低点82.15港元，较6月1日ASCO数据公布后高点累计跌幅逾25%。消息面上，该股延续ASCO利好兑现后的持续回调走势。此前公司核心产品依沃西联合化疗HARMONi-6研究在ASCO全体会议公布OS阳性结果，事件驱动型资金在利好落地后持续获利了结。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09926":"康方生物"},"translate_title":"Interpretation of the change | Kangfang Biotech fell 3.35% in the intraday session, and ASCO continued its correction and fell to near the 52-week low after the positive realization","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09926":1},"content_text":"6月10日，康方生物盘中下跌3.35%，报85.85港元，成交额3.65亿港元，股价已逼近52周低点82.15港元，较6月1日ASCO数据公布后高点累计跌幅逾25%。消息面上，该股延续ASCO利好兑现后的持续回调走势。此前公司核心产品依沃西联合化疗HARMONi-6研究在ASCO全体会议公布OS阳性结果，事件驱动型资金在利好落地后持续获利了结。同时，外媒关于美方可能限制对中国生物技术领域投资的传闻持续扰动市场情绪，生物科技板块整体承压，信达生物跌2.26%、百济神州跌0.31%、荣昌生物跌1.37%。尽管近期多家机构维持买入评级并给出远高于当前股价的目标价，但短线抛压与板块资金外流仍主导股价走势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1125573325","isCrawlerRequest":true}